Richard Anthony Cunningham

Insider Reports History

Entity
Individual
Location
One Kendall Square, Building 200 Suite 2, Cambridge, MA
Signature
/s/ Daniel George, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard Anthony Cunningham:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Anebulo Pharmaceuticals, Inc. Chief Executive Officer, Director Stock Option (right to buy) 254K Dec 9, 2024 Direct
TYME TECHNOLOGIES, INC. Chief Executive Officer Employee Stock Option - Option to buy 0 Sep 16, 2022 Direct

Insider Reports Filed by Richard Anthony Cunningham

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ANEB Anebulo Pharmaceuticals, Inc. Dec 9, 2024 1 $0 4 Dec 10, 2024 Chief Executive Officer, Director
ANEB Anebulo Pharmaceuticals, Inc. Oct 6, 2023 1 $0 4 Oct 11, 2023 Chief Executive Officer, Director
ANEB Anebulo Pharmaceuticals, Inc. Oct 6, 2023 0 $0 3 Oct 11, 2023 Chief Executive Officer, Director
TYME TYME TECHNOLOGIES, INC. Sep 16, 2022 3 $0 4 Sep 16, 2022 Chief Executive Officer
TYME TYME TECHNOLOGIES, INC. Apr 25, 2022 1 $0 4 Apr 26, 2022 Chief Executive Officer
TYME TYME TECHNOLOGIES, INC. Jun 14, 2021 1 $0 4 Jun 16, 2021 Chief Executive Officer